Medical History Dataset in Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections

Description of medical history, including timing and status of conditions
Study Description
An open-label, multiple-dose study to determine the safety, tolerability, and pharmacokinetics of meropenem in preterm and term infants less than 91 days of age with suspected or confirmed intra-abdominal infections. Biospecimens are available.
Infants less than 91 days of age with suspected or confirmed intra-abdominal infection

病史描述，涵盖疾病发作时间与病情状态
研究描述
本研究为开放标签多剂量临床试验，旨在评估美罗培南（meropenem）在疑似或确诊腹腔内感染且年龄小于91天的早产及足月婴儿中的安全性、耐受性与药代动力学。可提供生物标本（biospecimens）。
年龄小于91天、疑似或确诊腹腔内感染的婴儿